NCT05116319View on ClinicalTrials.gov

Prediction to Detect Pre-DM/DM in a Chinese Population

CompletedOBSERVATIONAL
Enrollment

1,901

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

August 29, 2023

Study Completion Date

October 31, 2023

Conditions
Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

point-of-care HbA1c

The Afinion2™ (Abbott, Oslo, Norway), will be used for the current study as it is recently validated. According to American Diabetes Association (ADA), pre-diabetes (pre-DM) is diagnosed if HbA1c is 5.7-6.4% and diabetes (DM) is diagnosed if HbA1c is ≥6.5%

Trial Locations (1)

Unknown

School of public health and primary care, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER